TAKE Solutions Limited (TAKE.BO)
INR 16.89
(-0.18%)
INR 16.89
(-0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 396.91 Million INR | -60.4% |
| 2022 | 1 Billion INR | -80.72% |
| 2021 | 5.19 Billion INR | -29.35% |
| 2020 | 7.35 Billion INR | -52.02% |
| 2019 | 15.33 Billion INR | 24.34% |
| 2018 | 12.33 Billion INR | 33.03% |
| 2017 | 9.27 Billion INR | 20.19% |
| 2016 | 7.71 Billion INR | 144.61% |
| 2015 | 3.15 Billion INR | 36.57% |
| 2014 | 2.3 Billion INR | -12.9% |
| 2013 | 2.65 Billion INR | -41.4% |
| 2012 | 4.52 Billion INR | 32.91% |
| 2011 | 3.4 Billion INR | 37.27% |
| 2010 | 2.47 Billion INR | 404.43% |
| 2009 | 491.6 Million INR | 13.43% |
| 2008 | 433.41 Million INR | 60.33% |
| 2007 | 270.33 Million INR | 49.04% |
| 2006 | 181.38 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 127.29 Million INR | 132.6% |
| 2023 FY | 396.91 Million INR | -60.4% |
| 2023 Q4 | 207.28 Million INR | 233.95% |
| 2023 Q3 | 62.07 Million INR | -50.19% |
| 2023 Q2 | 124.61 Million INR | -2.11% |
| 2022 Q1 | 434.19 Million INR | -11.8% |
| 2022 FY | 1 Billion INR | -80.72% |
| 2022 Q4 | -390.43 Million INR | -197.83% |
| 2022 Q3 | 399.09 Million INR | -24.64% |
| 2022 Q2 | 529.57 Million INR | 21.97% |
| 2021 Q3 | 1.86 Billion INR | 26.26% |
| 2021 Q2 | 1.47 Billion INR | 3.29% |
| 2021 FY | 5.19 Billion INR | -29.35% |
| 2021 Q1 | 1.42 Billion INR | 21.98% |
| 2021 Q4 | 492.25 Million INR | -73.58% |
| 2020 FY | 7.35 Billion INR | -52.02% |
| 2020 Q3 | 1.85 Billion INR | -23.7% |
| 2020 Q2 | 2.43 Billion INR | 28.13% |
| 2020 Q4 | 1.17 Billion INR | -36.9% |
| 2020 Q1 | 1.89 Billion INR | -52.87% |
| 2019 Q4 | 4.02 Billion INR | -0.88% |
| 2019 Q1 | 3.54 Billion INR | 8.98% |
| 2019 Q2 | 3.69 Billion INR | 4.21% |
| 2019 Q3 | 4.06 Billion INR | 9.91% |
| 2019 FY | 15.33 Billion INR | 24.34% |
| 2018 Q1 | 2.72 Billion INR | 2.59% |
| 2018 Q4 | 3.25 Billion INR | -1.46% |
| 2018 FY | 12.33 Billion INR | 33.03% |
| 2018 Q3 | 3.3 Billion INR | 8.22% |
| 2018 Q2 | 3.05 Billion INR | 12.12% |
| 2017 Q1 | 2.03 Billion INR | -0.07% |
| 2017 Q2 | 2.2 Billion INR | 8.43% |
| 2017 FY | 9.27 Billion INR | 20.19% |
| 2017 Q3 | 2.38 Billion INR | 8.17% |
| 2017 Q4 | 2.65 Billion INR | 11.2% |
| 2016 FY | 7.71 Billion INR | 144.61% |
| 2016 Q3 | 1.94 Billion INR | 2.7% |
| 2016 Q4 | 2.03 Billion INR | 4.96% |
| 2016 Q2 | 1.88 Billion INR | 2.18% |
| 2016 Q1 | 1.84 Billion INR | 4.9% |
| 2015 Q4 | 1.76 Billion INR | 21.96% |
| 2015 FY | 3.15 Billion INR | 36.57% |
| 2015 Q3 | 1.44 Billion INR | 94.34% |
| 2015 Q1 | 540.39 Million INR | -22.69% |
| 2015 Q2 | 743.58 Million INR | 37.6% |
| 2014 Q2 | 1.07 Billion INR | 106.76% |
| 2014 FY | 2.3 Billion INR | -12.9% |
| 2014 Q4 | 699 Million INR | 21.13% |
| 2014 Q3 | 577.07 Million INR | -46.19% |
| 2014 Q1 | 518.69 Million INR | -58.8% |
| 2013 Q2 | 1.26 Billion INR | 104.52% |
| 2013 Q4 | 1.25 Billion INR | 91.89% |
| 2013 Q1 | 617.02 Million INR | -49.03% |
| 2013 FY | 2.65 Billion INR | -41.4% |
| 2013 Q3 | 656.13 Million INR | -48.01% |
| 2012 FY | 4.52 Billion INR | 32.91% |
| 2012 Q4 | 1.21 Billion INR | 4.08% |
| 2012 Q3 | 1.16 Billion INR | 4.93% |
| 2012 Q2 | 1.1 Billion INR | 4.88% |
| 2012 Q1 | 1.05 Billion INR | 5.96% |
| 2011 Q3 | 803.41 Million INR | 3.47% |
| 2011 Q2 | 776.49 Million INR | 0.0% |
| 2011 FY | 3.4 Billion INR | 37.27% |
| 2011 Q4 | 997.45 Million INR | 24.15% |
| 2010 FY | 2.47 Billion INR | 404.43% |
| 2009 FY | 491.6 Million INR | 13.43% |
| 2008 FY | 433.41 Million INR | 60.33% |
| 2007 FY | 270.33 Million INR | 49.04% |
| 2006 FY | 181.38 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -31908.871% |
| Biocon Limited | 40.9 Billion INR | 99.03% |
| Blue Jet Healthcare Limited | 531.85 Million INR | 25.372% |
| Concord Biotech Limited | 1.45 Billion INR | 72.809% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 92.289% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | 47.374% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -105742.667% |
| Lyka Labs Limited | 599.4 Million INR | 33.783% |
| Panacea Biotec Limited | 1.99 Billion INR | 80.109% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -26406.965% |
| Servoteach Industries Limited | 785.00 INR | -50561683.439% |
| SMS Lifesciences India Limited | 602.96 Million INR | 34.174% |
| Supriya Lifescience Limited | 1.08 Billion INR | 63.254% |
| Syngene International Limited | 5.99 Billion INR | 93.379% |
| Titan Biotech Limited | 117.05 Million INR | -239.074% |
| Transgene Biotek Limited | 5.39 Million INR | -7254.271% |
| Vanta Bioscience Limited | 38.95 Million INR | -918.815% |